DUSP1 and apparent mineralocorticoid excess: Our study demonstrates that the up-regulation of miR-34a-3p negatively regulates DUSP1 expression to inhibit PASMCs proliferation, which, therefore, may be a potential target for the treatment of APE by negatively regulating pulmonary vascular proliferation.